Cargando…
Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
Aberrant activation of Wnt/β-catenin signaling plays a central role in the pathogenesis of a wide variety of malignancies and is typically caused by mutations in core Wnt pathway components driving constitutive, ligand-independent signaling. In multiple myelomas (MMs), however, these pathway intrins...
Autores principales: | van Andel, Harmen, Kocemba, Kinga A., Spaargaren, Marcel, Pals, Steven T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756057/ https://www.ncbi.nlm.nih.gov/pubmed/30770859 http://dx.doi.org/10.1038/s41375-019-0404-1 |
Ejemplares similares
-
Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma
por: Kocemba, Kinga A., et al.
Publicado: (2012) -
The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma
por: Ren, Zemin, et al.
Publicado: (2021) -
Correction to: The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma
por: Ren, Zemin, et al.
Publicado: (2021) -
Influence of metformin on HIF-1 pathway in multiple myeloma
por: Kocemba-Pilarczyk, Kinga A., et al.
Publicado: (2020) -
Molecular genetic aberrations in the pathogenesis of multiple myeloma
por: Bong, Ivyna Pau Ni, et al.
Publicado: (2023)